Copyright
©The Author(s) 2020.
World J Clin Cases. Jun 26, 2020; 8(12): 2473-2483
Published online Jun 26, 2020. doi: 10.12998/wjcc.v8.i12.2473
Published online Jun 26, 2020. doi: 10.12998/wjcc.v8.i12.2473
Table 3 Receiver-operating characteristic curve analysis of serum growth differentiation factor 15 levels as a potential multiple system atrophy diagnostic biomarker
Group | Subtype | AUC | SE | 95%CI | P value | Cutoff, pg/mL | Sensitivity, % | Specificity, % |
MSA vs Control | Overall | 0.929 | 0.027 | 0.876-0.981 | 0.000 | 470.42 | 85.7 | 88.0 |
Male | 0.954 | 0.030 | 0.896-1.000 | 0.000 | 552.10 | 82.6 | 100.0 | |
Female | 0.905 | 0.044 | 0.820-0.990 | 0.000 | 470.42 | 80.8 | 90.0 | |
MSA vs PD | Overall | 0.765 | 0.048 | 0.671-0.859 | 0.000 | 1075.91 | 51.0 | 96.0 |
Male | 0.772 | 0.072 | 0.630-0.914 | 0.001 | 1075.91 | 65.2 | 95.8 | |
Female | 0.783 | 0.066 | 0.654-0.911 | 0.000 | 616.39 | 65.4 | 88.5 |
- Citation: Yue T, Lu H, Yao XM, Du X, Wang LL, Guo DD, Liu YM. Elevated serum growth differentiation factor 15 in multiple system atrophy patients: A case control study. World J Clin Cases 2020; 8(12): 2473-2483
- URL: https://www.wjgnet.com/2307-8960/full/v8/i12/2473.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i12.2473